Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 129


Astaxanthin supplementation modulates cognitive function and synaptic plasticity in young and aged mice.

Grimmig B, Hudson C, Moss L, Peters M, Subbarayan M, Weeber EJ, Bickford PC.

Geroscience. 2019 Feb;41(1):77-87. doi: 10.1007/s11357-019-00051-9. Epub 2019 Feb 9.


Long noncoding RNA MALAT1 in exosomes drives regenerative function and modulates inflammation-linked networks following traumatic brain injury.

Patel NA, Moss LD, Lee JY, Tajiri N, Acosta S, Hudson C, Parag S, Cooper DR, Borlongan CV, Bickford PC.

J Neuroinflammation. 2018 Jul 12;15(1):204. doi: 10.1186/s12974-018-1240-3.


Astaxanthin is neuroprotective in an aged mouse model of Parkinson's disease.

Grimmig B, Daly L, Subbarayan M, Hudson C, Williamson R, Nash K, Bickford PC.

Oncotarget. 2017 Dec 28;9(12):10388-10401. doi: 10.18632/oncotarget.23737. eCollection 2018 Feb 13.


HIV Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Reduces Neural Stem Cell Proliferation in Vitro and in Vivo.

Jin J, Grimmig B, Izzo J, Brown LAM, Hudson C, Smith AJ, Tan J, Bickford PC, Giunta B.

Cell Transplant. 2016 Nov;25(11):1967-1977. doi: 10.3727/096368916X691457.


Proteomic anaysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response.

Flowers A, Bell-Temin H, Jalloh A, Stevens SM Jr, Bickford PC.

J Neuroinflammation. 2017 May 3;14(1):96. doi: 10.1186/s12974-017-0840-7.


Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration.

Grimmig B, Kim SH, Nash K, Bickford PC, Douglas Shytle R.

Geroscience. 2017 Feb;39(1):19-32. doi: 10.1007/s11357-017-9958-x. Epub 2017 Feb 13. Review.


Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases.

Bickford PC, Flowers A, Grimmig B.

Exp Gerontol. 2017 Aug;94:4-8. doi: 10.1016/j.exger.2017.01.027. Epub 2017 Feb 2. Review.


MALAT1 in Human Adipose Stem Cells Modulates Survival and Alternative Splicing of PKCδII in HT22 Cells.

El Bassit G, Patel RS, Carter G, Shibu V, Patel AA, Song S, Murr M, Cooper DR, Bickford PC, Patel NA.

Endocrinology. 2017 Jan 1;158(1):183-195. doi: 10.1210/en.2016-1819.


Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson's Disease.

Grimmig B, Morganti J, Nash K, Bickford PC.

Brain Sci. 2016 Sep 23;6(4). pii: E41. doi: 10.3390/brainsci6040041. Review.


Erratum to: NT-020 treatment reduces inflammation and augments Nrf-2 and Wnt signaling in aged rats.

Flowers A, Lee JY, Grimmig B, Acosta S, Hudson C, Small B, Sanberg CD, Bickford PC.

J Neuroinflammation. 2016 Sep 5;13(1):229. No abstract available.


Novel Molecular Insights into Classical and Alternative Activation States of Microglia as Revealed by Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based Proteomics.

Bell-Temin H, Culver-Cochran AE, Chaput D, Carlson CM, Kuehl M, Burkhardt BR, Bickford PC, Liu B, Stevens SM Jr.

Mol Cell Proteomics. 2015 Dec;14(12):3173-84. doi: 10.1074/mcp.M115.053926. Epub 2015 Sep 30.


Nutraceutical intervention reverses the negative effects of blood from aged rats on stem cells.

Bickford PC, Kaneko Y, Grimmig B, Pappas C, Small B, Sanberg CD, Sanberg PR, Tan J, Douglas Shytle R.

Age (Dordr). 2015 Oct;37(5):103. doi: 10.1007/s11357-015-9840-7. Epub 2015 Sep 26.


NT-020 treatment reduces inflammation and augments Nrf-2 and Wnt signaling in aged rats.

Flowers A, Lee JY, Acosta S, Hudson C, Small B, Sanberg CD, Bickford PC.

J Neuroinflammation. 2015 Sep 17;12:174. doi: 10.1186/s12974-015-0395-4. Erratum in: J Neuroinflammation. 2016;13(1):229.


Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.

Shahaduzzaman M, Nash K, Hudson C, Sharif M, Grimmig B, Lin X, Bai G, Liu H, Ugen KE, Cao C, Bickford PC.

PLoS One. 2015 Feb 6;10(2):e0116841. doi: 10.1371/journal.pone.0116841. eCollection 2015.


Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration.

Nash KR, Moran P, Finneran DJ, Hudson C, Robinson J, Morgan D, Bickford PC.

Mol Ther. 2015 Jan;23(1):17-23. doi: 10.1038/mt.2014.175. Epub 2014 Sep 8.


Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats.

Tajiri N, Acosta SA, Shahaduzzaman M, Ishikawa H, Shinozuka K, Pabon M, Hernandez-Ontiveros D, Kim DW, Metcalf C, Staples M, Dailey T, Vasconcellos J, Franyuti G, Gould L, Patel N, Cooper D, Kaneko Y, Borlongan CV, Bickford PC.

J Neurosci. 2014 Jan 1;34(1):313-26. doi: 10.1523/JNEUROSCI.2425-13.2014.


Nutraceutical intervention improves older adults' cognitive functioning.

Small BJ, Rawson KS, Martin C, Eisel SL, Sanberg CD, McEvoy CL, Sanberg PR, Shytle RD, Tan J, Bickford PC.

Rejuvenation Res. 2014 Feb;17(1):27-32. doi: 10.1089/rej.2013.1477.


α-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury.

Shahaduzzaman M, Acosta S, Bickford PC, Borlongan CV.

Med Hypotheses. 2013 Oct;81(4):675-80. doi: 10.1016/j.mehy.2013.07.025. Epub 2013 Aug 6.


Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.

Wecker L, Engberg ME, Philpot RM, Lambert CS, Kang CW, Antilla JC, Bickford PC, Hudson CE, Zesiewicz TA, Rowell PP.

Neuropharmacology. 2013 Oct;73:75-86. doi: 10.1016/j.neuropharm.2013.05.016. Epub 2013 May 24.


Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy.

Nash KR, Lee DC, Hunt JB Jr, Morganti JM, Selenica ML, Moran P, Reid P, Brownlow M, Guang-Yu Yang C, Savalia M, Gemma C, Bickford PC, Gordon MN, Morgan D.

Neurobiol Aging. 2013 Jun;34(6):1540-8. doi: 10.1016/j.neurobiolaging.2012.12.011. Epub 2013 Jan 16.


Supplemental Content

Loading ...
Support Center